Latest Publications
Improved Pharma Expands Pharmaceutical Development Services with New Automated Dissolution Capabilities
Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development WEST LAFAYETTE, Ind., Feb. 11, 2026 /PRNewswire/ -- Improved Pharma, a leader in pharmaceutical research and solid-state chemistry, is pleased to announce a significant upgrade to its analyticalRead more
Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development
Steve Byrn and David Engers Improved Pharma Feb. 11, 2026 Improved Pharma has recently expanded its dissolution capabilities by installing a fully automated Agilent 708-DS dissolution apparatus paired with the 850-DS autosampler. This capabilityRead more
Improved Pharma Announces Enhanced X-Ray Diffraction and Interpretation Services to Strengthen Market Authorization Applications and Patents
Expanded solid-state characterization services now deliver advanced X-ray diffraction, expert interpretation, and regulatory-ready data for market authorization and patents. WEST LAFAYETTE, Ind., Feb. 9, 2026 /PRNewswire/ -- Improved Pharma is pleased to announce the expansion ofRead more
The High-Quality Difference: Solid-State Data That Stands Up to FDA and Patent Review
Authors Jared Smit, David Engers, Steve Byrn In modern small-molecule development, solid-state characterization is far more than a routine analytical task.(Byrn, Zografi et al. 2025) It defines the manufacturable form of an API, supportsRead more
Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs
WEST LAFAYETTE, Ind., Jan. 27, 2026 /PRNewswire/ -- Improved Pharma is pleased to share that our research on the crystal structure of Ritonavir Form IV has been published in the highly reputable and peer-reviewed journal, CrystalRead more
New Edition of Seminal Text “Solid-State Materials in Pharmaceutical Chemistry” Released by Industry Leaders
The updated second edition delivers expanded insights into solid-state pharmaceutical materials, reflecting major scientific and regulatory advances in drug development. WEST LAFAYETTE, Ind., Jan. 7, 2026 /PRNewswire/ -- Improved Pharma is proud to announce the releaseRead more
Categories
Recent News
- Improved Pharma Expands Pharmaceutical Development Services with New Automated Dissolution Capabilities
- Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development
- Improved Pharma Announces Enhanced X-Ray Diffraction and Interpretation Services to Strengthen Market Authorization Applications and Patents
- The High-Quality Difference: Solid-State Data That Stands Up to FDA and Patent Review
- Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs
Solving Pharmaceutical Problems
We are a research and information company dedicated to improving pharmaceutical methods, formulations, and processes.






